BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Colorcon
McKinsey
Medtronic
Cipla
Queensland Health
Citi
AstraZeneca
Chubb

Generated: January 21, 2018

DrugPatentWatch Database Preview

Mestranol; norethindrone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mestranol; norethindrone and what is the scope of mestranol; norethindrone patent protection?

Mestranol; norethindrone
is the generic ingredient in fourteen branded drugs marketed by Actavis Labs Ut Inc, Watson Labs, Gd Searle Llc, Ortho Mcneil Pharm, and Ortho Mcneil Janssen, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for mestranol; norethindrone. Two suppliers are listed for this compound.
Summary for mestranol; norethindrone

US Patents and Regulatory Information for mestranol; norethindrone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc NORINYL 1+50 28-DAY mestranol; norethindrone TABLET;ORAL-28 016659-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ortho Mcneil Pharm ORTHO-NOVUM 2-21 mestranol; norethindrone TABLET;ORAL-21 012728-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc NORINYL mestranol; norethindrone TABLET;ORAL-20 013625-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ortho Mcneil Janssen ORTHO-NOVUM 1/50 28 mestranol; norethindrone TABLET;ORAL-28 016709-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ortho Mcneil Pharm ORTHO-NOVUM 1/80 21 mestranol; norethindrone TABLET;ORAL-21 016715-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc NORINYL 1+50 21-DAY mestranol; norethindrone TABLET;ORAL-21 013625-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs NORETHIN 1/50M-28 mestranol; norethindrone TABLET;ORAL-28 071540-001 Apr 12, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs NORETHIN 1/50M-21 mestranol; norethindrone TABLET;ORAL-21 071539-001 Apr 12, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ortho Mcneil Pharm ORTHO-NOVUM 1/50 21 mestranol; norethindrone TABLET;ORAL-21 012728-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ortho Mcneil Pharm ORTHO-NOVUM 1/80 28 mestranol; norethindrone TABLET;ORAL-28 016715-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Julphar
Teva
Johnson and Johnson
Daiichi Sankyo
Covington
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot